Follow Us:
Thursday, January 23, 2020

Daiichi Sankyo


Ex-Ranbaxy promoters Malvinder, Shivinder guilty of contempt: SC

November 15, 2019 1:06 pm

The Supreme Court said the Singh brothers violated its order asking them not to divest their shares in Fortis Healthcare Limited.

Malvinder and Shivinder Singh and the ‘missing’ funds of a billion-dollar empire

April 15, 2019 7:02 am

The Indian Express reviews various allegations raised over the last year of diversion of funds previously held by the ex-promoters of Fortis and Ranbaxy.

Daiichi-Ranbaxy row: Delhi High Court allows sale of Singh brothers' firms

May 08, 2018 7:19 pm

The Delhi High Court issued notice to Daiichi on a plea by the brothers seeking a stay on the enforcement proceedings, as a Singapore court has reserved its judgment in an appeal by them against Daiichi's award.

Daiichi Sankyo case: Delhi HC orders seizure of Singh brothers’ assets

February 27, 2018 1:00 am

The court’s order came on the petition of Japanese drug maker Daiichi Sankyo for enforcement of the Rs 3,500-crore international arbitration award that it has won against the brothers.

2008 Ranbaxy stake sale: Singh brothers asked to pay Rs 2,562 cr to Daiichi Sankyo

May 06, 2016 1:40 am

Ex-promoters ‘concealed and misrepresented information’: Singapore tribunal.

Daiichi Sankyo to sell stake worth R22,500 crore in Sun Pharma

April 21, 2015 2:14 am

Daiichi Sankyo received 21.5 crore shares of Sun Pharma following the completion of Sun Pharma’s merger with Ranbaxy Laboratories.

Daiichi plea in HC to vacate stay on Ranbaxy merger

May 12, 2014 3:38 am

The petitioners alleged that there was heavy trading of Ranbaxy stock before the merger with Sun Pharma was announced on April 6.

Ranbaxy posts loss after write-offs on US bans

May 10, 2014 12:33 am

The Japan’s Daiichi Sankyo-owned firm made a provision of Rs 62.95 crore for inventory write-off and other costs.

Sun buys Ranbaxy for $3.2 bn in biggest Indian pharma deal

April 07, 2014 10:07 pm

Sun Pharmaceutical Industries Ltd will buy Ranbaxy Laboratories Ltd for $ 3.2 billion.

Ranbaxy Laboratories sale shows risk in Japanese M and A adventures

April 07, 2014 2:23 pm

Daiichi Sankyo is handing control of its ailing Ranbaxy to local rival Sun Pharmaceutical in $3.2 billion deal.